Cargando…

Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents

RATIONALE: Acute atherothrombotic occlusion in heart attack and stroke implies disruption of the vascular endothelial barrier that exposes a highly procoagulant intimal milieu. However, the evolution, severity, and pathophysiological consequences of vascular barrier damage in atherosclerotic plaque...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huiying, Zhang, Lei, Myerson, Jacob, Bibee, Kristin, Scott, Michael, Allen, John, Sicard, Gregorio, Lanza, Gregory, Wickline, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196552/
https://www.ncbi.nlm.nih.gov/pubmed/22028868
http://dx.doi.org/10.1371/journal.pone.0026385
_version_ 1782214221759512576
author Zhang, Huiying
Zhang, Lei
Myerson, Jacob
Bibee, Kristin
Scott, Michael
Allen, John
Sicard, Gregorio
Lanza, Gregory
Wickline, Samuel
author_facet Zhang, Huiying
Zhang, Lei
Myerson, Jacob
Bibee, Kristin
Scott, Michael
Allen, John
Sicard, Gregorio
Lanza, Gregory
Wickline, Samuel
author_sort Zhang, Huiying
collection PubMed
description RATIONALE: Acute atherothrombotic occlusion in heart attack and stroke implies disruption of the vascular endothelial barrier that exposes a highly procoagulant intimal milieu. However, the evolution, severity, and pathophysiological consequences of vascular barrier damage in atherosclerotic plaque remain unknown, in part because quantifiable methods and experimental models are lacking for its in vivo assessment. OBJECTIVE: To develop quantitative nondestructive methodologies and models for detecting vascular barrier disruption in advanced plaques. METHODS AND RESULTS: Sustained hypercholesterolemia in New Zealand White (NZW) rabbits for >7–14 months engendered endothelial barrier disruption that was evident from massive and rapid passive penetration and intimal trapping of perfluorocarbon-core nanoparticles (PFC-NP: ∼250 nm diameter) after in vivo circulation for as little as 1 hour. Only older plaques (>7 mo), but not younger plaques (<3 mo) demonstrated the marked enhancement of endothelial permeability to these particles. Electron microscopy revealed a complex of subintimal spongiform channels associated with endothelial apoptosis, superficial erosions, and surface-penetrating cholesterol crystals. Fluorine ((19)F) magnetic resonance imaging and spectroscopy (MRI/MRS) enabled absolute quantification (in nanoMolar) of the passive permeation of PFC-NP into the disrupted vascular lesions by sensing the unique spectral signatures from the fluorine core of plaque-bound PFC-NP. CONCLUSIONS: The application of semipermeant nanoparticles reveals the presence of profound barrier disruption in later stage plaques and focuses attention on the disrupted endothelium as a potential contributor to plaque vulnerability. The response to sustained high cholesterol levels yields a progressive deterioration of the vascular barrier that can be quantified with fluorine MRI/MRS of passively permeable nanostructures. The possibility of plaque classification based on the metric of endothelial permeability to nanoparticles is suggested.
format Online
Article
Text
id pubmed-3196552
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31965522011-10-25 Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents Zhang, Huiying Zhang, Lei Myerson, Jacob Bibee, Kristin Scott, Michael Allen, John Sicard, Gregorio Lanza, Gregory Wickline, Samuel PLoS One Research Article RATIONALE: Acute atherothrombotic occlusion in heart attack and stroke implies disruption of the vascular endothelial barrier that exposes a highly procoagulant intimal milieu. However, the evolution, severity, and pathophysiological consequences of vascular barrier damage in atherosclerotic plaque remain unknown, in part because quantifiable methods and experimental models are lacking for its in vivo assessment. OBJECTIVE: To develop quantitative nondestructive methodologies and models for detecting vascular barrier disruption in advanced plaques. METHODS AND RESULTS: Sustained hypercholesterolemia in New Zealand White (NZW) rabbits for >7–14 months engendered endothelial barrier disruption that was evident from massive and rapid passive penetration and intimal trapping of perfluorocarbon-core nanoparticles (PFC-NP: ∼250 nm diameter) after in vivo circulation for as little as 1 hour. Only older plaques (>7 mo), but not younger plaques (<3 mo) demonstrated the marked enhancement of endothelial permeability to these particles. Electron microscopy revealed a complex of subintimal spongiform channels associated with endothelial apoptosis, superficial erosions, and surface-penetrating cholesterol crystals. Fluorine ((19)F) magnetic resonance imaging and spectroscopy (MRI/MRS) enabled absolute quantification (in nanoMolar) of the passive permeation of PFC-NP into the disrupted vascular lesions by sensing the unique spectral signatures from the fluorine core of plaque-bound PFC-NP. CONCLUSIONS: The application of semipermeant nanoparticles reveals the presence of profound barrier disruption in later stage plaques and focuses attention on the disrupted endothelium as a potential contributor to plaque vulnerability. The response to sustained high cholesterol levels yields a progressive deterioration of the vascular barrier that can be quantified with fluorine MRI/MRS of passively permeable nanostructures. The possibility of plaque classification based on the metric of endothelial permeability to nanoparticles is suggested. Public Library of Science 2011-10-18 /pmc/articles/PMC3196552/ /pubmed/22028868 http://dx.doi.org/10.1371/journal.pone.0026385 Text en Zhang et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Zhang, Huiying
Zhang, Lei
Myerson, Jacob
Bibee, Kristin
Scott, Michael
Allen, John
Sicard, Gregorio
Lanza, Gregory
Wickline, Samuel
Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents
title Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents
title_full Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents
title_fullStr Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents
title_full_unstemmed Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents
title_short Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents
title_sort quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196552/
https://www.ncbi.nlm.nih.gov/pubmed/22028868
http://dx.doi.org/10.1371/journal.pone.0026385
work_keys_str_mv AT zhanghuiying quantifyingtheevolutionofvascularbarrierdisruptioninadvancedatherosclerosiswithsemipermeantnanoparticlecontrastagents
AT zhanglei quantifyingtheevolutionofvascularbarrierdisruptioninadvancedatherosclerosiswithsemipermeantnanoparticlecontrastagents
AT myersonjacob quantifyingtheevolutionofvascularbarrierdisruptioninadvancedatherosclerosiswithsemipermeantnanoparticlecontrastagents
AT bibeekristin quantifyingtheevolutionofvascularbarrierdisruptioninadvancedatherosclerosiswithsemipermeantnanoparticlecontrastagents
AT scottmichael quantifyingtheevolutionofvascularbarrierdisruptioninadvancedatherosclerosiswithsemipermeantnanoparticlecontrastagents
AT allenjohn quantifyingtheevolutionofvascularbarrierdisruptioninadvancedatherosclerosiswithsemipermeantnanoparticlecontrastagents
AT sicardgregorio quantifyingtheevolutionofvascularbarrierdisruptioninadvancedatherosclerosiswithsemipermeantnanoparticlecontrastagents
AT lanzagregory quantifyingtheevolutionofvascularbarrierdisruptioninadvancedatherosclerosiswithsemipermeantnanoparticlecontrastagents
AT wicklinesamuel quantifyingtheevolutionofvascularbarrierdisruptioninadvancedatherosclerosiswithsemipermeantnanoparticlecontrastagents